Suppr超能文献

羟氯喹诱导的急性泛发性脓疱性皮病伴HLA分型

Hydroxychloroquine-induced acute generalized exanthematous pustulosis with HLA-typing.

作者信息

Zheng Qiaoli, Jin Na, Cheng Hao

机构信息

Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

出版信息

Pharmacogenomics. 2024;25(14-15):569-572. doi: 10.1080/14622416.2024.2430167. Epub 2024 Nov 18.

Abstract

Acute generalized exanthematous pustulosis (AGEP) is a rare drug reaction characterized by numerous pustules on an erythematous base. In some cases, hydroxychloroquine (HCQ) can cause AGEP. There is an association between HLA genes and AGEP according to pharmacogenomic studies. In this case report, we present the case of a 36-year-old female who developed HCQ-induced AGEP with HLA-typing. According to our findings, the patient had HLA-B 58:01, HLA-C 08:01, and HLA-A 02:06. A pharmacoeconomic perspective of HLA genotyping before drug prescription is shown in this result.

摘要

急性泛发性脓疱性皮病(AGEP)是一种罕见的药物反应,其特征为在红斑基础上出现大量脓疱。在某些情况下,羟氯喹(HCQ)可导致AGEP。根据药物基因组学研究,HLA基因与AGEP之间存在关联。在本病例报告中,我们呈现了一名36岁女性发生HCQ诱导的AGEP并进行HLA分型的病例。根据我们的研究结果,该患者具有HLA - B 58:01、HLA - C 08:01和HLA - A 02:06。此结果显示了在药物处方前进行HLA基因分型的药物经济学观点。

相似文献

1
Hydroxychloroquine-induced acute generalized exanthematous pustulosis with HLA-typing.
Pharmacogenomics. 2024;25(14-15):569-572. doi: 10.1080/14622416.2024.2430167. Epub 2024 Nov 18.
4
The First Pediatric Case of Acute Generalized Exanthematous Pustulosis Caused by Hydroxychloroquine.
Pharmacology. 2019;104(1-2):57-59. doi: 10.1159/000500406. Epub 2019 May 8.
5
Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation.
An Bras Dermatol. 2017 May-Jun;92(3):404-406. doi: 10.1590/abd1806-4841.20175561.
6
Hydroxychloroquine-induced acute generalized exanthematous pustulosis (AGEP) treated with secukinumab.
J Eur Acad Dermatol Venereol. 2024 Sep;38(9):e769-e771. doi: 10.1111/jdv.19875. Epub 2024 Feb 24.
8
Acute localized exanthematous pustulosis: Clinical features, pathophysiology, and therapy.
Dermatol Ther. 2021 Sep;34(5):e15087. doi: 10.1111/dth.15087. Epub 2021 Aug 25.

本文引用的文献

1
Association between alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions.
Front Pharmacol. 2023 Sep 19;14:1248386. doi: 10.3389/fphar.2023.1248386. eCollection 2023.
2
Genotyping alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art.
Expert Opin Drug Metab Toxicol. 2021 Sep;17(9):1049-1064. doi: 10.1080/17425255.2021.1946514. Epub 2021 Jul 8.
3
Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic review.
J Am Acad Dermatol. 2020 Aug;83(2):563-578. doi: 10.1016/j.jaad.2020.04.024. Epub 2020 Apr 11.
4
Does hydroxychloroquine combat COVID-19? A timeline of evidence.
J Am Acad Dermatol. 2020 Jul;83(1):e33-e34. doi: 10.1016/j.jaad.2020.04.031. Epub 2020 Apr 10.
5
Cephalexin-induced acute generalized exanthematous pustulosis.
Dermatol Reports. 2018 Oct 1;10(2):7686. doi: 10.4081/dr.2018.7686.
6
Culprit Drugs Induce Specific IL-36 Overexpression in Acute Generalized Exanthematous Pustulosis.
J Invest Dermatol. 2019 Apr;139(4):848-858. doi: 10.1016/j.jid.2018.10.023. Epub 2018 Nov 2.
8
Hydroxychloroquine-Induced Erythema Multiforme.
J Clin Rheumatol. 2017 Mar;23(2):127-128. doi: 10.1097/RHU.0000000000000417.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验